Of Course 23andMe's Plan Has Been to Sell Your Genetic Data All Along

Today, 23andMe announced what Forbes reports is only the first of ten deals with big biotech companies: Genentech will pay up to $60 million for access to 23andMe's data to study Parkinson's. You think 23andMe was about selling fun DNA spit tests for $99 a pop? Nope, it's been about selling your data all along. » 1/06/15 3:35pm 1/06/15 3:35pm

Why We Need to Think Differently About Our Genomes

If—like most of us—your entire understanding of DNA and genetics can be traced back to CSI reruns, you’re probably under the impression that your genome is unique; that it defines you completely. But scientists increasingly believe that’s not that case. In fact, we need to start thinking about our genomes differently. » 9/20/13 9:40am 9/20/13 9:40am